Friday, June 8, 2012
Lunch Time Boob Job With Macrolane Discontinued
Macrolane for breast enhancement, also known as the 'lunch time boob job' has been taken off the market since April 2012. Q-Med, the manufacturer of Macrolane, has decided to discontinue the promotion of Macrolane for breast enhancement worldwide.
Photo source : C.P. Storm, Flickr.com
Macrolane breast enhancement does not increase the risk of breast cancer but may increase the risk of a delayed diagnosis.
Macrolane is an injectable filler used for multiple indications including “lunchtime boob jobs”. The cosmetic treatment works by enhancing breast size without the need for implants. It was believed to be less invasive than surgical breast augmentation.
Experts warn that the injected filler material could affect breast cancer screenings but Q-Med said there was a lack of consensus amongst radiologists regarding examination of breasts treated with injectable products.
Macrolane will still remain available for non-breast related body contouring procedures such as buttock enhancement and to correct post liposuction deformities. Meanwhile, according to Q Med, women who have undergone breast enhancement by Macrolane injections do not need to take any action and are not subject to specific medical follow-up other than as prescribed by their practitioner following the procedure.
Article source : BBC